Therapeutic compound/extract/protein | Drosophila model (gene knockdown/knockout) | Phenotype/s modified | Mechanism of action | References |
---|---|---|---|---|
Polyphenols: Propyl gallate, Epigallocathecin | parkin | Improved lifespan and attenuated climbing defects | Inhibits ROS accumulation and prevents iron induced neurotoxicity | |
Zinc chloride | parkin | Improved lifespan and locomotor ability | Impedes ROS-induced apoptosis | [165] |
Nicotine | parkin | Improved lifespan, viability, locomotor ability and reduced olfactory deficits | Promotes activity of complex I and reduces the production of ROS via the ETS | |
Minocycline | parkin | Improved lifespan and locomotor ability | Protects against iron and paraquat induced toxicity and scavenges ROS | [166] |
Folic acid | parkin | Improved lifespan and locomotor ability | Downregulates p53, PGC1α and ATP levels (promotes mitochondrial biogenesis and ROS clearance) | [163] |
Sulforaphane | parkin | Suppressed dopaminergic neuron loss | Stimulates Nrf2 induced transcription of antioxidant enzymes | |
Resveratrol /Grape skin extract (GSE) | pink1 | Improved lifespan, wing posture, locomotor ability and larval mitochondrial morphology | Upregulates p62 receptor expression and mitophagy | [170] |
Ginseng protein | pink1 | Improved wing posture, locomotor ability and suppressed dopaminergic neuron loss | Triggers unfolded protein response (promotes mitochondrial biogenesis) and protects against rotenone/paraquat induced toxicity | [171] |
Mucuna pruriens | pink1 | Improved SOD and GSH levels | Increases clearance of ROS by upregulating antioxidant enzyme activity | [167] |
Recombinant SOD1 + Vitamin E | pink1 | Reduced ommatidial and retinal degeneration and suppressed dopaminergic neuron loss | Protects against ROS-induced cell death (scavenges ROS) | [180] |
Vitamin K2 | pink1 | Improved locomotor ability and larval mitochondrial morphology | Acts as an ETS carrier analogous to ubiquinone and thereby promotes oxidative phosphorylation | [169] |